Methods for treating multiple sclerosis
OwnerShi Yan, David Sterninventors
Life of this patent
Estimating the term…
Abstract
This invention provides a method for treating a subject afflicted with multiple sclerosis comprising administering to the subject a therapeutically effective amount of soluble receptor for advanced glycation endproducts (sRAGE). This invention further provides a method for inhibiting CD4+ T-cell migration comprising contacting the CD4+ T-cell with soluble receptor for advanced glycation endproducts (sRAGE). This invention further provides a method for inhibiting chemokine receptor activation in a subject comprising administering to the subject a therapeutically effective amount of soluble receptor for advanced glycation endproducts (sRAGE).
Claims19
A method for treating a subject afflicted with multiple sclerosis comprising administering to the subject a therapeutically effective amount of soluble receptor for advanced glycation endproducts (sRAGE).
A method for inhibiting CD4+ T-cell migration comprising contacting the CD4+ T-cell with soluble receptor for advanced glycation endproducts (sRAGE).
A method for inhibiting chemokine receptor activation in a subject comprising administering to the subject a therapeutically effective amount of soluble receptor for advanced glycation endproducts (sRAGE).
19-21. (canceled)
Dependencies are inferred from the claim text.